Economic burden of child sexual abuse in U.S. : insufficient data on males

The multi-trillion-dollar cost of sexual violence: Research roundup

Letourneau, Elizabeth J.; et al. Child Abuse & Neglect. May 2018.

The researchers tabulate the economic costs of child sexual abuse nationally, including costs related to health care, productivity loss, child welfare, violence and crime, special education and suicide. For this research, productivity loss means a victim or survivor’s potential loss of earnings stemming from sexual abuse that occurred during childhood.

  • The authors estimate there were more than 40,000 new, nonfatal cases of child sexual abuse and 20 new fatal cases in 2015.
  • The average lifetime cost for female and male victims of nonfatal child sexual abuse tops $282,000 — though most of this total is due to productivity loss and information on productivity loss for males was insufficient, according to the authors.
  • The lifetime economic burden of fatal and nonfatal child sexual abuse is $9.3 billion.!

The present study provides an estimate of the U.S. economic impact of child sexual abuse (CSA). Costs of CSA were measured from the societal perspective and include health care costs, productivity losses, child welfare costs, violence/crime costs, special education costs, and suicide death costs. We separately estimated quality-adjusted life year (QALY) losses. For each category, we used the best available secondary data to develop cost per case estimates. All costs were estimated in U.S. dollars and adjusted to the reference year 2015. Estimating 20 new cases of fatal and 40,387 new substantiated cases of nonfatal CSA that occurred in 2015, the lifetime economic burden of CSA is approximately $9.3 billion, the lifetime cost for victims of fatal CSA per female and male victim is on average $1,128,334 and $1,482,933, respectively, and the average lifetime cost for victims of nonfatal CSA is of $282,734 per female victim. For male victims of nonfatal CSA, there was insufficient information on productivity losses, contributing to a lower average estimated lifetime cost of $74,691 per male victim. If we included QALYs, these costs would increase by approximately $40,000 per victim. With the exception of male productivity losses, all estimates were based on robust, replicable incidence-based costing methods. The availability of accurate, up-to-date estimates should contribute to policy analysis, facilitate comparisons with other public health problems, and support future economic evaluations of CSA-specific policy and practice. In particular, we hope the availability of credible and contemporary estimates will support increased attention to primary prevention of CSA.